Results
1 -
10 of
11Sabarubicin, Anthracycline Chemistry and Biology II Anthracycline Cardiotoxicity, Anthracycline Chemistry and Biology II Pharmacokinetics of MEN-10755, a novel anthracycline disaccharide analogue, in two phase I studies in adults with advanced solid tumours, Cancer Chemotherapy and Pharmacology Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755, Cancer Chemotherapy and Pharmacology In vitro modeling of the structureu2013activity determinants of anthracycline cardiotoxicity, Cell Biology and Toxicology A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer, Investigational New Drugs Ongoing phase I and II studies of novel anthracyclines, Cardiovascular Toxicology A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer, Investigational New Drugs